Jalisco mutation, rare strain of Alzheimer's affecting people in their 40s

December 15, 2017 by Ron Mackovich, University of Southern California
Maria Barocio, 45, who has early-onset Alzheimer’s, walks with her doctor, Freddi Segal-Gidan, at the Rancho Los Amigos National Rehabilitation Center. Credit: USC Photo/Gus Ruelas

Freddi Segal-Gidan, known as "Dr. Freddi" to her patients, talks softly as she walks with an Alzheimer's patient.

As it turns out, the doctor's patient is just 45 years old.

"Maria has four children, and the youngest is only 3," Segal-Gidan said. "Her husband can't work because he's a full-time caregiver."

Symptoms of Alzheimer's disease began showing when Maria Barocio was in her early 40s. She has what's known as the Jalisco gene mutation, which causes early-onset Alzheimer's. Maria is among the 1 percent of Alzheimer's patients who have genetic known to cause the disease.

Segal-Gidan is ana ssociate professor of clinical neurology at the Keck School of Medicine of USC. Together with USC neurologist Helena Chang Chui, she directs the Geriatric Nuerobehavior and Alzheimer's Center at Rancho Los Amigos in Downey, where they care for about a dozen families affected by the Jalisco gene mutation.

"It's heartrending when we see these patients going through Alzheimer's at age 40," Chui said. "Their children are still in school and they have to watch their father or mother go through this decline."

Superstitions and misdiagnosis

Jalisco gene patients are descended from a common ancestor, and they have roots in Mexico's state of Jalisco. The mutation, identified in 2006, spread through generations of large families and a limited gene pool.

"In small villages, when someone suffers from dementia in their early 40s, it's taboo," Segal-Gidan said. "There is a belief they were cursed in some way."

Physicians aren't usually looking for Alzheimer's in a 40-year-old patient, and they sometimes initially misdiagnose Jalisco patients as schizophrenic.

Debilitating stiffness in the limbs, common in Jalisco patients, can mislead doctors to incorrectly conclude that multiple sclerosis is the cause.

Jalisco mutation, rare strain of Alzheimer’s affecting people in their 40s
Patients with the Jalisco mutation are descended from a common ancestor in Mexico and have a high incidence of Alzheimer’s.  Credit: USC Photo/Gus Ruelas

The next generation

Sons and daughters of Jalisco patients are faced with stark choices. They have a 50 percent chance of carrying the mutation, which can be determined with a blood test. A positive result brings the prognosis of early-onset Alzheimer's and the risk of passing on the mutation to children.

"Some decide not to get tested," Chui said. "They don't want to know. For those who do, we have a genetic counselor ready in case they get a positive result."

Pre-symptomatic Jalisco carriers face decisions about whether to get married and have children. They can also consider in-vitro testing for the mutation during pregnancy, and plan career and life choices with the knowledge they will develop the Alzheimer's relatively early.

"I hope we can stop the spread of this mutation by educating the families so they can speak honestly with their children," Segal-Gidan said. "We want them to understand they have some control of their own destiny, and make decisions about being tested and procreating."

A rare opportunity for research

Chui and Segal-Gidan refer some patients and their families to John Ringman, a USC researcher who's been studying the Jalisco mutation for almost two decades. A number of Ringman's patients travel to California, where he hopes to extend research and education efforts.

"I saw my first Jalisco patient in 1999," Ringman said. "I wasn't particularly interested in dementia at the beginning of my career. Then I saw these families getting Alzheimer's in their 40s. This isn't a phenomenon of aging, and I thought if we can learn to prevent this, my life's work will be accomplished."

Jalisco mutation carriers give researchers like Ringman an unusual edge in the fight against Alzheimer's. The timeline of their disease development is pre-set. Biological changes that accompany Alzheimer's can be monitored before symptoms surface, and medications can be tested to see if they slow or mitigate the disease.

"If we ever find an effective medication, I'll be out of a job—and I'd love that," he said.

Connecting with care

"Some of our patients can't work. They were fired," Segal-Gidan said. "They've paid into the system and they should have access to disability, but they need help navigating the process. Some have even faced deportation because they weren't able to pass a citizenship test."

At Rancho Los Amigos, Jalisco patients and their families are connected with social services and support networks. Clinicians and social workers assist with applications for in-home services, insurance coverage and emotional support. Medication is monitored and adjusted to help patients with symptoms like depression.

"We can also adjust medication to make some of our patients easier to care for," Segal-Gidan said. "We want to keep these families together and keep our at home as long as they can be there. That's really my hope."

Explore further: Children of patients with C9orf72 mutations are at a greater risk of frontotemporal dementia or ALS at a younger age

Related Stories

Children of patients with C9orf72 mutations are at a greater risk of frontotemporal dementia or ALS at a younger age

February 14, 2017
The most common genetic cause of the brain diseases frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) is a mutation in the C9orf72 gene. Researchers from VIB and UAntwerp, headed by Prof. Christine Van ...

Mum in her 30s discusses realities of life with a 75% chance of Alzheimer's

August 22, 2017
With a one in over 600 million chance of her parents both having the same rare, inherited gene, a young mum has spoken of the anguish of knowing she has a 75 percent risk of developing Alzheimer's in just a few years, and ...

Early Alzheimer's gene spells tragedy for patients, opportunity for science

January 10, 2017
Rosemary Navarro was living in Mexico when her brother called from California. Something wasn't right with their mom, then in her early 40s. She was having trouble paying bills and keeping jobs as a food preparer in convalescent ...

Alzheimer's-plagued Colombia region is focus of drug trial

December 17, 2012
The unusually high incidence of early-onset Alzheimer's disease in this isolated cattle town has thrust it to the forefront of global efforts to find a cure for the debilitating malady.

A new gene thought to be the cause in early-onset forms of Alzheimer's disease

April 4, 2012
A new gene that causes early-onset of Alzheimer's disease has been discovered by the research team of Dominique Campion at the Insert unit 1079 "Genetics of cancer and neuropsychiatric diseases" in Rouen. The research scientists ...

Newly identified rare Alzheimer's disease gene mutation more common in Icelandic people

October 20, 2016
People with Icelandic heritage are more likely to carry a novel rare mutation in the TM2D3 gene, which leads to greater risk for Alzheimer's disease, based on a new study published October 14th, 2016 in PLOS Genetics by Johanna ...

Recommended for you

Rocky start for Alzheimer's drug research in 2018

January 19, 2018
The year 2018, barely underway, has already dealt a series of disheartening blows to the quest for an Alzheimer's cure.

Alzheimer's disease: Neuronal loss very limited

January 17, 2018
Frequently encountered in the elderly, Alzheimer's is considered a neurodegenerative disease, which means that it is accompanied by a significant, progressive loss of neurons and their nerve endings, or synapses. A joint ...

Anxiety: An early indicator of Alzheimer's disease?

January 12, 2018
A new study suggests an association between elevated amyloid beta levels and the worsening of anxiety symptoms. The findings support the hypothesis that neuropsychiatric symptoms could represent the early manifestation of ...

One of the most promising drugs for Alzheimer's disease fails in clinical trials

January 11, 2018
To the roughly 400 clinical trials that have tested some experimental treatment for Alzheimer's disease and come up short, we can now add three more.

Different disease types associated with distinct amyloid-beta prion strains found in Alzheimer's patients

January 9, 2018
An international team of researchers has found different disease type associations with distinct amyloid-beta prion strains in the brains of dead Alzheimer's patients. In their paper published in Proceedings of the National ...

Advances in brain imaging settle debate over spread of key protein in Alzheimer's

January 5, 2018
Recent advances in brain imaging have enabled scientists to show for the first time that a key protein which causes nerve cell death spreads throughout the brain in Alzheimer's disease - and hence that blocking its spread ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.